001     140525
005     20240123114653.0
024 7 _ |a 10.1016/j.brainres.2018.11.042
|2 doi
024 7 _ |a pmid:30503351
|2 pmid
024 7 _ |a 0006-8993
|2 ISSN
024 7 _ |a 1872-6240
|2 ISSN
024 7 _ |a altmetric:52142837
|2 altmetric
024 7 _ |a 10.60944/dzne-2020-06847
|2 datacite_doi
037 _ _ |a DZNE-2020-06847
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Ambrad Giovannetti, Eleonora
|0 P:(DE-2719)2811489
|b 0
|e First author
245 _ _ |a Unsupervised excitation: GABAergic dysfunctions in Alzheimer's disease.
260 _ _ |a Amsterdam
|c 2019
|b Elsevier
264 _ 1 |3 print
|2 Crossref
|b Elsevier BV
|c 2019-03-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1706001881_18610
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Alzheimer's disease (AD) is characterized by the classical hallmarks of Aβ-deposition and tau-pathology that are thought to ultimately lead to synapse and neuron loss. Although long known, neuroinflammation has recently attracted a substantial amount of attention by researchers due to genome wide association studies (GWAS) that identified microglia associated genes to be correlated with sporadic AD. Besides that, cholinergic degeneration and gamma-aminobutyric acid (GABA) abnormalities have been identified in the brains of AD patients already decades ago, but have not received much attention over the last ten years. Recently, the neuronal network dysfunction hypothesis has revived interest in how impairments of neuronal communication at the network level lead to epileptiform activity and disrupted oscillations observed in the brains of AD patients and mouse models. Thereby, deficits in neuronal networks involved in learning and memory might ultimately cause memory impairments. In this context, an imbalance between excitation and inhibition has been hypothesized to contribute to neuronal network dysfunction. Here, disturbances of cholinergic and GABAergic transmission might play a crucial role. In this review, we will focus on GABAergic dysfunction in AD and mouse models of AD and how those might relate to neuronal network aberration and memory impairment.
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 0
542 _ _ |i 2019-03-01
|2 Crossref
|u https://www.elsevier.com/tdm/userlicense/1.0/
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 2 |a Alzheimer Disease: physiopathology
|2 MeSH
650 _ 2 |a Amyloid beta-Peptides: metabolism
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Brain: metabolism
|2 MeSH
650 _ 2 |a Disease Models, Animal
|2 MeSH
650 _ 2 |a GABAergic Neurons: metabolism
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Memory: physiology
|2 MeSH
650 _ 2 |a Memory Disorders: pathology
|2 MeSH
650 _ 2 |a Nerve Degeneration: pathology
|2 MeSH
650 _ 2 |a Nerve Net: physiopathology
|2 MeSH
650 _ 2 |a Neurons: metabolism
|2 MeSH
650 _ 2 |a gamma-Aminobutyric Acid: metabolism
|2 MeSH
650 _ 2 |a tau Proteins: metabolism
|2 MeSH
700 1 _ |a Fuhrmann, Martin
|0 P:(DE-2719)2679991
|b 1
|e Last author
773 1 8 |a 10.1016/j.brainres.2018.11.042
|b : Elsevier BV, 2019-03-01
|p 216-226
|3 journal-article
|2 Crossref
|t Brain Research
|v 1707
|y 2019
|x 0006-8993
773 _ _ |a 10.1016/j.brainres.2018.11.042
|g Vol. 1707, p. 216 - 226
|0 PERI:(DE-600)1462674-3
|q 1707<216 - 226
|p 216-226
|t Brain research
|v 1707
|y 2019
|x 0006-8993
856 4 _ |u https://pub.dzne.de/record/140525/files/DZNE-2020-06847_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/140525/files/DZNE-2020-06847.pdf
|y Published on 2019-03-15. Available in OpenAccess from 2020-03-15.
|z StatID:(DE-HGF)0510
856 4 _ |u https://pub.dzne.de/record/140525/files/DZNE-2020-06847.pdf?subformat=pdfa
|x pdfa
|y Published on 2019-03-15. Available in OpenAccess from 2020-03-15.
|z StatID:(DE-HGF)0510
856 4 _ |u https://pub.dzne.de/record/140525/files/DZNE-2020-06847_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |o oai:pub.dzne.de:140525
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2811489
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2679991
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms and Model Systems
|x 0
914 1 _ |y 2019
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-09
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a Embargoed OpenAccess
|0 StatID:(DE-HGF)0530
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BRAIN RES : 2021
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-09
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2022-11-09
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-09
915 _ _ |a Green Open Access
|0 StatID:(DE-HGF)0514
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-09
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-09
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-09
920 1 _ |0 I:(DE-2719)1011004
|k AG Fuhrmann
|l Neuroimmunology and Imaging
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1011004
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21